Tag Archives: OTCMKTS:CBIS

Cannabis Science Inc (OTCMKTS:CBIS) Announced The Delivery Notification Of First Greenhouse Orders

Cannabis Science Inc (OTCMKTS:CBIS) is delighted to announce that the delivery of the first of the per-designed greenhouses that have full tracking and reporting protocols. Numerous inquires The company specializes in development of cannabis related medicine is excited with the … Continue reading

Posted in Announcements, Virmmac Blogs | Tagged , , | Comments Off on Cannabis Science Inc (OTCMKTS:CBIS) Announced The Delivery Notification Of First Greenhouse Orders

$CBIS – Cannabis Science, Inc. News

CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW! NEUNKIRCHEN-RICHELBACH, GERMANY–(Marketwired – Jun 2, 2016) –  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced … Continue reading

Posted in Blogs, Virmmac Blogs | Tagged , , | Comments Off on $CBIS – Cannabis Science, Inc. News

$CBIS – Health for Humans and Their Furry Loved Ones

Cannabis Science has been on the cutting-edge with becoming one of the earliest adopters in the legal cannabis industry. Though the industry is young, Cannabis Science continues to push the boundaries by producing new and innovative product offerings. The company … Continue reading

Posted in Virmmac Blogs | Tagged , , , | Comments Off on $CBIS – Health for Humans and Their Furry Loved Ones

$CBIS News – Cannabis Science, Inc. Takes Final Steps by Filing Dividend Paperwork With FINRA, While It Transitions Into the Equi-Pharm Acquisition and Its New Product Offerings

COLORADO SPRINGS, CO–(Marketwired – Oct 30, 2015) – Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines is pleased to announce that following the Schedule 14C Dividend filing, the Company has now filed … Continue reading

Posted in Blogs | Tagged , , , | Comments Off on $CBIS News – Cannabis Science, Inc. Takes Final Steps by Filing Dividend Paperwork With FINRA, While It Transitions Into the Equi-Pharm Acquisition and Its New Product Offerings